000			02039 a2200553 4500
005			20250517001812.0
264		0	_c20150827
008			201508s 0 0 eng d
022			_a1399-3062
024	7		_a10.1111/tid.12309 _2doi
040			_aNLM _beng _cNLM
100	1		_aMarchesi, F
245	0	0	_aEvaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study. _h[electronic resource]
260			_bTransplant infectious disease : an official journal of the Transplantation Society _cDec 2014
300			_a1032-8 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aBoronic Acids _xadministration & dosage
650	0	4	_aBortezomib
650	0	4	_aCytomegalovirus Infections _xpathology
650	0	4	_aDexamethasone _xadministration & dosage
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xtherapy
650	0	4	_aPyrazines _xadministration & dosage
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aStem Cell Transplantation
650	0	4	_aVincristine _xadministration & dosage
700	1		_aPimpinelli, F
700	1		_aDessanti, M L
700	1		_aGumenyuk, S
700	1		_aPalombi, F
700	1		_aPisani, F
700	1		_aRomano, A
700	1		_aSpadea, A
700	1		_aMaschio, M
700	1		_aEnsoli, F
700	1		_aMengarelli, A
773	0		_tTransplant infectious disease : an official journal of the Transplantation Society _gvol. 16 _gno. 6 _gp. 1032-8
856	4	0	_uhttps://doi.org/10.1111/tid.12309 _zAvailable from publisher's website
999			_c24328645 _d24328645